DHFR and neoplasm: Methotrexate is an anti-folate drug, and can inhibit dihydrofolate reductase, thus preventing the DNA synthesis of tumor cells, inhibiting the growth and proliferation of tumor cells and exerting antitumor effects (Djerassi, 1967; Bertino, 1979).